** Shares of medtech company TransMedics Group TMDX.O rise 1.6% to $130.79
** Piper Sandler raises TMDX's PT to $145 from $125
** Piper believes TMDX is on track to beat sales estimates for Q2, which could continue stock's strong momentum seen in recent months
** While there was a slight decline in plane volumes in May compared to April, brokerage believes TMDX continues to see strong adoption of its aviation services
** TMDX still appears positioned to deliver sequential quarterly growth in its logistics business given May flight volumes were higher than each month in Q1 - Piper
** TMDX up 106.5% YTD, as of last close
(Reporting by Juby Babu in Mexico City)
((Juby.Babu@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.